Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BTCY Biotricity	$0.53 +10.4%	$0.44	$0.19 ▼ $0.83	$13.20M	1.12	38,264 shs	9,323 shs
DXR Daxor	$11.00 +1.5%	$9.81	$6.55 ▼ $11.38	$52.42M	-0.13	79,638 shs	3,712 shs
GUTS Fractyl Health	$1.02 +3.0%	$1.55	$0.83 ▼ $3.72	$49.79M	1.66	1.32 million shs	1.38 million shs
MLSS Milestone Scientific	$0.60 +1.5%	$0.65	$0.38 ▼ $1.39	$47.37M	0.8	213,162 shs	67,239 shs

The Best High-Yield Dividend Stocks for 2025

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BTCY Biotricity	-3.03%	-11.11%	-5.88%	-5.88%	+14.83%
DXR Daxor	+1.50%	+2.17%	+18.08%	+40.05%	+27.98%
GUTS Fractyl Health	+1.02%	+1.29%	-46.77%	-45.00%	-67.00%
MLSS Milestone Scientific	-0.67%	+2.56%	-7.36%	-40.30%	-40.49%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BTCY Biotricity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
DXR Daxor	4.2723 of 5 stars	3.5	5.0	0.0	0.0	3.3	1.7	0.0
GUTS Fractyl Health	1.6727 of 5 stars	3.5	2.0	0.0	0.0	0.7	1.7	0.0
MLSS Milestone Scientific	2.4207 of 5 stars	3.5	3.0	0.0	0.0	1.5	2.5	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BTCY Biotricity	2.00	Hold	N/A	N/A
DXR Daxor	3.00	Buy	$25.00	127.27% Upside
GUTS Fractyl Health	3.00	Buy	$8.00	684.31% Upside
MLSS Milestone Scientific	3.00	Buy	$1.25	107.30% Upside

Current Analyst Ratings Breakdown

Latest BTCY, MLSS, DXR, and GUTS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
8/14/2025	GUTS Fractyl Health	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$12.00 ➝ $6.00

(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BTCY Biotricity	$12.06M	1.09	N/A	N/A	($1.30) per share	-0.41
DXR Daxor	$2.13M	24.97	N/A	N/A	N/A	∞
GUTS Fractyl Health	$90K	569.95	N/A	N/A	($0.36) per share	-2.83
MLSS Milestone Scientific	$9.08M	5.22	N/A	N/A	$0.11 per share	5.48

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BTCY Biotricity	-$14.09M	-$0.21	N/A	∞	N/A	-80.42%	N/A	-188.47%	N/A
DXR Daxor	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
GUTS Fractyl Health	-$68.69M	-$2.06	N/A	N/A	N/A	-73,864.52%	-584.35%	-102.88%	N/A
MLSS Milestone Scientific	-$6.93M	-$0.09	N/A	∞	N/A	-52.01%	-60.26%	-40.23%	N/A

Latest BTCY, MLSS, DXR, and GUTS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/12/2025	Q2 2025	GUTS Fractyl Health	-$0.37	-$0.53	-$0.16	-$0.57	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BTCY Biotricity	N/A	N/A	N/A	N/A	N/A
DXR Daxor	$0.03	0.27%	N/A	N/A	N/A
GUTS Fractyl Health	N/A	N/A	N/A	N/A	N/A
MLSS Milestone Scientific	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BTCY Biotricity	N/A	0.23	0.10
DXR Daxor	N/A	N/A	N/A
GUTS Fractyl Health	4.61	1.22	1.22
MLSS Milestone Scientific	N/A	2.85	1.86

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BTCY Biotricity	3.89%
DXR Daxor	1.34%
GUTS Fractyl Health	N/A
MLSS Milestone Scientific	5.79%

Insider Ownership

Company	Insider Ownership
BTCY Biotricity	10.10%
DXR Daxor	59.50%
GUTS Fractyl Health	27.00%
MLSS Milestone Scientific	24.75%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BTCY Biotricity	40	24.91 million	22.08 million	Optionable
DXR Daxor	37	4.84 million	1.96 million	Not Optionable
GUTS Fractyl Health	102	50.29 million	36.71 million	N/A
MLSS Milestone Scientific	30	78.56 million	58.61 million	Optionable

BTCY, MLSS, DXR, and GUTS Headlines

Recent News About These Companies

Milestone Scientific, Inc.: Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025

August 16, 2025 | finanznachrichten.de

Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025

August 14, 2025 | globenewswire.com

Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call

August 13, 2025 | globenewswire.com

Milestone Scientific Appoints Jason Papes as Senior Vice President, Global Head of Sales and Marketing

August 6, 2025 | globenewswire.com

Milestone Scientific Appoints Eric C. Hines as Chief Executive Officer

August 1, 2025 | globenewswire.com

Milestone Scientific Commences Sales of CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey

July 17, 2025 | globenewswire.com

S.R.L. Bp4 Sells 30,558 Shares of Milestone Scientific Inc. (NYSE:MLSS) Stock

July 11, 2025 | insidertrades.com

MLSS Milestone Scientific Inc. - Seeking Alpha

June 27, 2025 | seekingalpha.com

Milestone Scientific Inc. (MLSS) - Yahoo Finance

June 27, 2025 | finance.yahoo.com

S.R.L. Bp4 Sells 23,797 Shares of Milestone Scientific Inc. (NYSE:MLSS) Stock

June 17, 2025 | insidertrades.com

Kalkine : NYSE Composite Sees MLSS Movement Amid Light Trading Volume

June 10, 2025 | kalkinemedia.comK

Milestone Scientific Inc. (NYSE:MLSS) Major Shareholder S.R.L. Bp4 Sells 14,256 Shares

May 31, 2025 | insidertrades.com

Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors

May 19, 2025 | globenewswire.com

Milestone Scientific, Inc.: Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025

May 17, 2025 | finanznachrichten.de

Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025

May 16, 2025 | manilatimes.netM

Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025

May 15, 2025 | globenewswire.com

Why Milestone Scientific Inc.’s (MLSS) Stock Is Down 5.50%

May 5, 2025 | aaii.comA

Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025

April 15, 2025 | markets.businessinsider.com

Why Milestone Scientific Inc.’s (MLSS) Stock Is Up 7.95%

April 9, 2025 | aaii.comA

Why Milestone Scientific Inc.’s (MLSS) Stock Is Up 10.53%

April 2, 2025 | aaii.comA

New MarketBeat Followers Over Time

Media Sentiment Over Time

BTCY, MLSS, DXR, and GUTS Company Descriptions

Biotricity NASDAQ:BTCY

$0.53 +0.05 (+10.42%)

As of 03:51 PM Eastern

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Daxor NASDAQ:DXR

$11.00 +0.16 (+1.48%)

As of 02:28 PM Eastern

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

Fractyl Health NASDAQ:GUTS

$1.02 +0.03 (+3.03%)

Closing price 04:00 PM Eastern

Extended Trading

$1.02 +0.00 (+0.39%)

As of 07:56 PM Eastern

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Milestone Scientific NYSE:MLSS

$0.60 +0.01 (+1.53%)

Closing price 03:56 PM Eastern

Extended Trading

$0.60 0.00 (-0.50%)

As of 06:50 PM Eastern

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time